Form 4 for PLRX PLIANT THERAPEUTICS, INC.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-23 · accession 0001746473-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-24 | 2024-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +31.5K | 86.7K | +57% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-23 | A | A | 31,500 | $0.00 | 86,746 | D | — | — | (F1) These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-23 | A | A | 63,000 | $0.00 | 63,000 | D | $17.44 · — to 2034-01-23 | 63,000 Common Stock | (F2) 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date. |